In the News... Teplizumab approved, Twitter mess for Lilly, Medtronic 7-day infusion set launches, and more!

Diabetes Connections | Type 1 Diabetes · Nov 18, 2022 · 1m

It's in the News.. the top diabetes stories of the past seven days. This week, the first drug to prevent T1D for any length of time is approved, Eli Lilly takes a financial hit from a Twitter impersonation stunt, Medtronic's 7-day pump infusion set is ready for consumers, Dexcom's G7 gets great reviews from older folks and educators for ease of use, a new study about light at night and diabetes and more!

Learn more about the T1D Exchange: www.t1dexchange.com/stacey

Check out Stacey's book: The World's Worst Diabetes Mom!

Join the Diabetes Connections Facebook Group!

Sign up for our newsletter…